Introduction: Male breast cancer is a rare diagnosis, representing less than 1% of breast cancers. However, in comparison to females, fewer males are referred to breast clinics. By comparing the breast cancer diagnosis rate for males and females in a symptomatic clinic, this study aimed to ...
“Thyroid cancer in women is well treated and has a high survival rate, but thyroid cancer in men is more likely to recur and has a poorer prognosis than women, even if it is the same size, so men need to be more careful when they develop thyroid cancer,” Professor Han said. Althoug...
Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the male population. MBC incidence is generally low compared with the female breast cancer (FBC), the highest rates adjusted for age occur in Israel (0.08 per 100,000 person-years), while the rates are...
Relapse rate was 71.4% (15/21). The median disease free survival period was 20 months, one-year disease free survival was 58% and the five-year disease free survival was 21.1%. Although the existence of NCI-UG has facilitated MBC patients treatment, but the general impact of healthcare ...
Methods: From 1 January 1990 to 31 December 2014, the data of 152 MBC and 304 female breast cancer (FBC) patients were identified and extensively compared. Results: Compared with the FBC group, MBC patients were found to have a higher rate of cancer family history (30.9% vs. 18.4%, P ...
The overall mortality rate was similar to the background population(SMR of 1.00, 95 %CI 0.96–1.04) and was not affected by the timing of their birth in relation to father’s cancer diagnosis. Conclusion Male cancer survivors are less likely to father a child compared to the background ...
The majority (81.3%) of cases occurred in white men (median age, 68 years). The cancer was more likely to occur on the left side, at a rate of 52.3%. Most cases were either regional (43.8%) or localized (46.4%) at the time of diagnosis. ...
Data obtained, included initial stage, pathological features, treatment and outcomes.Results: With a median follow up of 4.9 years (range 2 months to 19 years) the 5-year overall survival (OS) rate was 85% with median survival of 5.5 years. In all, 18 (29%) were diagnosed with ...
We observed 11 cases of male breast cancer versus 16.16 expected based on national rates (standardized rate ratio 0.68, 95% confidence interval 0.34–1.22) and conclude that any adverse influence of in utero oestrogen exposure is likely to be small. 2000 Cancer Research Campaign...
Fifty consecutive cases of male breast cancer (MBC) treated in a single institution were studied. Presentation of the disease, histology, pattern of relapse, and major prognostic factors were similar to those known in female breast cancer (FBC). Five-year disease-free interval and survival were ...